MArS Market Access & Pricing Strategy is a specialized consulting agency in the health care market access area with a special focus and experience in the following key areas: • Market access & pricing as well as global clinical development strategies from a health care payer's perspective in the various lifecycle stages of a product (Phase I-Phase IV) • German market access strategies and implementation for pharmaceuticals (AMNOG: German Law for Reforming the Market for Pharmaceuticals) and medical devices • Swiss and Austrian market access strategies and implementation for parmaceuticals